Abstract

In an attempt to find novel α-glucosidase inhibitors, an efficient, straightforward reaction to synthesize a library of fully substituted 6-amino-pyrazolo[1,5-a]pyrimidines 3 has been investigated. Heating a mixture of α-azidochalcones 1 and 3-aminopyrazoles 2 under the mild condition afforded desired compounds with a large substrate scope in good to excellent yields. All obtained products were evaluated as α-glucosidase inhibitors and exhibited excellent potency with IC50 values ranging from 15.2 ± 0.4 µM to 201.3 ± 4.2 µM. Among them, compound 3d was around 50-fold more potent than acarbose (IC50 = 750.0 ± 1.5 µM) as standard inhibitor. Regarding product structures, kinetic study and molecular docking were carried out for two of the most potent ones.

Details

Title
An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity
Author
Peytam Fariba 1 ; Adib Mehdi 2 ; Shourgeshty Reihaneh 1 ; Firoozpour Loghman 3 ; Rahmanian-Jazi Mahmoud 3 ; Jahani Mehdi 2 ; Moghimi Setareh 3 ; Divsalar Kouros 4 ; Faramarzi Mohammad Ali 5 ; Mojtabavi Somayeh 5 ; Safari Fatemeh 6 ; Mahdavi Mohammad 7 ; Foroumadi Alireza 8 

 School of Chemistry, College of Science, University of Tehran, Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950); Department of Medicinal Chemistry, Faculty of Pharmacy and The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922) 
 School of Chemistry, College of Science, University of Tehran, Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950) 
 Department of Medicinal Chemistry, Faculty of Pharmacy and The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922) 
 Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran (GRID:grid.412105.3) (ISNI:0000 0001 2092 9755) 
 Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922) 
 Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250) 
 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922) 
 Department of Medicinal Chemistry, Faculty of Pharmacy and The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922); Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran (GRID:grid.412105.3) (ISNI:0000 0001 2092 9755) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2354718767
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.